- Home
- ZLAB vs TWST Comparison
ZLAB vs TWST Comparison
Compare ZLAB & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- TWST
- Stock Information
- Founded
- ZLAB 2013
- TWST 2013
- Country
- ZLAB China
- TWST United States
- Employees
- ZLAB N/A
- TWST N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZLAB Health Care
- TWST Health Care
- Exchange
- ZLAB Nasdaq
- TWST Nasdaq
- Market Cap
- ZLAB 3.6B
- TWST 2.2B
- IPO Year
- ZLAB 2017
- TWST 2018
- Fundamental
- Price
- ZLAB $35.20
- TWST $38.27
- Analyst Decision
- ZLAB Buy
- TWST Buy
- Analyst Count
- ZLAB 5
- TWST 10
- Target Price
- ZLAB $54.28
- TWST $49.10
- AVG Volume (30 Days)
- ZLAB 839.0K
- TWST 1.0M
- Earning Date
- ZLAB 08-05-2025
- TWST 08-01-2025
- Dividend Yield
- ZLAB N/A
- TWST N/A
- EPS Growth
- ZLAB N/A
- TWST N/A
- EPS
- ZLAB N/A
- TWST N/A
- Revenue
- ZLAB $418,326,000.00
- TWST $347,680,000.00
- Revenue This Year
- ZLAB $44.07
- TWST $22.58
- Revenue Next Year
- ZLAB $49.13
- TWST $17.71
- P/E Ratio
- ZLAB N/A
- TWST N/A
- Revenue Growth
- ZLAB 43.72
- TWST 25.30
- 52 Week Low
- ZLAB $16.01
- TWST $27.12
- 52 Week High
- ZLAB $44.34
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- ZLAB 48.55
- TWST 60.80
- Support Level
- ZLAB $34.26
- TWST $35.44
- Resistance Level
- ZLAB $36.97
- TWST $38.86
- Average True Range (ATR)
- ZLAB 1.10
- TWST 1.92
- MACD
- ZLAB -0.41
- TWST 0.15
- Stochastic Oscillator
- ZLAB 23.98
- TWST 88.52
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.